Last reviewed · How we verify

The Mass Balance and Biotransformation of [14C] Vicagrel in Healthy Man

NCT04143750 PHASE1 COMPLETED

This study was designed to evaluate the mass balance and biotransformation after single-dose of \[14C\]Vicagrel orally in Chinese healthy male volunteers, revealing the overall pharmacokinetic characteristics of vicagrel in humans, and providing a reference for the rational administration.

Details

Lead sponsorJiangsu vcare pharmaceutical technology co., LTD
PhasePHASE1
StatusCOMPLETED
Enrolment6
Start dateMon Nov 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionTue Jan 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions

Countries

China